More frequently described as a "Jack-Of-All-Trades", Jack began researching cannabis under the NY-State Medical Marijuana program in 2014.
Since fruition Jack has worked with over 800 patients on the MMJ Program and conducted research ranging from applied therapeutic usage to barriers to care in the space. Jack has hopes to study lesser used cannabinoids such as CBN, D8, D10, CBDA, and more in applied conditions such as IBS, PTSD, Anxiety, and Epilepsy.